Purple Biotech Ltd
NASDAQ:PPBT
Balance Sheet
Balance Sheet Decomposition
Purple Biotech Ltd
Purple Biotech Ltd
Balance Sheet
Purple Biotech Ltd
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
11
|
7
|
4
|
5
|
4
|
11
|
11
|
15
|
14
|
7
|
|
| Cash Equivalents |
0
|
0
|
1
|
11
|
7
|
4
|
5
|
4
|
11
|
11
|
15
|
14
|
7
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
8
|
3
|
2
|
2
|
47
|
36
|
17
|
1
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
2
|
11
|
15
|
8
|
9
|
8
|
59
|
48
|
33
|
16
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
20
|
20
|
21
|
28
|
28
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+3 788%
|
2
+466%
|
11
+515%
|
15
+38%
|
14
-5%
|
15
+4%
|
15
0%
|
84
+469%
|
70
-16%
|
55
-22%
|
44
-19%
|
37
-16%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
2
|
2
|
1
|
1
|
1
|
2
|
4
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
0
|
3
|
0
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
0
|
1
|
5
|
0
|
1
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
1
|
4
|
3
|
4
|
3
|
4
|
7
|
7
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+203%
|
1
-22%
|
1
+40%
|
2
+11%
|
7
+343%
|
4
-38%
|
4
+2%
|
4
+3%
|
5
+22%
|
8
+44%
|
10
+31%
|
4
-59%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
4
|
8
|
13
|
17
|
29
|
34
|
37
|
40
|
59
|
79
|
99
|
115
|
|
| Additional Paid In Capital |
1
|
3
|
9
|
22
|
31
|
36
|
45
|
47
|
119
|
124
|
126
|
133
|
148
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
-132%
|
1
N/A
|
9
+1 120%
|
13
+42%
|
7
-45%
|
11
+42%
|
10
-1%
|
79
+662%
|
65
-18%
|
47
-28%
|
34
-27%
|
33
-4%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+3 788%
|
2
+466%
|
11
+515%
|
15
+38%
|
14
-5%
|
15
+4%
|
15
0%
|
84
+469%
|
70
-16%
|
55
-22%
|
44
-19%
|
37
-16%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
4
|
8
|
11
|
16
|
20
|
172
|
178
|
185
|
252
|
517
|
|